FUT4 is increased in leukaemia, gastric, breast and colorectal cancer; UGT2B17 is increased in endometrial cancer; POFUT1 is increased in glioblastomas and oral squamous cell carcinoma, and MAN2A1 is decreased in glioblastoma (Table 2). Here, MAN2A1 is linked to leukemia.